Automatic Website Traffic RSS

FDA approves over-the-counter Narcan for opioid OD reversal - New York Post

On Wednesday, the Food and Drug Administration approved the first over-the-counter nasal spray that rapidly reverses the effects of an opioid overdose. Narcan, a 4-milligram naloxone hydrochloride ... read more

FDA approves 1st nonopioid drug to ease withdrawal symptoms - WJLA

Wed, 26 Mar 2025 20:20:08 GMT (1743020408129) Story Infinite Scroll - News3 v1.0.0 (common) b73495c0160a5331e59eca6a7036842f21180665 ... read more

FDA Approves Generic of Lucemyra to Manage Opioid Withdrawal Symptoms

Lofexidine is administered during the period of peak withdrawal symptoms. The Food and Drug Administration (FDA) has approved Lofexidine Tablets 0.18mg, the first generic of Lucemyra. Lofexidine ... read more

FDA Approves Nalmefene Auto-Injector for Opioid Overdose

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency ... read more

FDA approves nonopioid Journavx for moderate to severe acute pain - Healio

In 2022, nearly 108,000 people tragically lost their lives to drug overdoses, with opioids accounting for approximately 82,000 of those deaths — roughly 76% of the total. read more